Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Centogene NV (CNTG)

Centogene NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNTG
DateTimeSourceHeadlineSymbolCompany
17/05/202412:20Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NASDAQ:CNTGCentogene NV
15/05/202422:17GlobeNewswire Inc.CENTOGENE Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:CNTGCentogene NV
15/05/202422:12Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:CNTGCentogene NV
15/05/202422:10GlobeNewswire Inc.CENTOGENE Secures Approx. $20 Million to Strengthen Cash PositionNASDAQ:CNTGCentogene NV
15/05/202422:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
15/05/202421:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
14/05/202413:30GlobeNewswire Inc.CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher DiseaseNASDAQ:CNTGCentogene NV
14/05/202413:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
10/05/202411:30GlobeNewswire Inc.CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse PatientsNASDAQ:CNTGCentogene NV
10/05/202411:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
02/04/202421:30GlobeNewswire Inc.CENTOGENE Receives Nasdaq Non-Compliance NoticeNASDAQ:CNTGCentogene NV
19/03/202410:30GlobeNewswire Inc.CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage DisordersNASDAQ:CNTGCentogene NV
29/02/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
29/02/202422:00GlobeNewswire Inc.CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα DeficiencyNASDAQ:CNTGCentogene NV
28/02/202411:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
28/02/202411:30GlobeNewswire Inc.CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a HearingNASDAQ:CNTGCentogene NV
28/02/202411:30GlobeNewswire Inc.CENTOGENE Explores Strategic AlternativesNASDAQ:CNTGCentogene NV
28/02/202411:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
25/01/202411:30GlobeNewswire Inc.CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationNASDAQ:CNTGCentogene NV
25/01/202411:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
24/01/202411:30GlobeNewswire Inc.CENTOGENE Receives French Research Tax Credit AccreditationNASDAQ:CNTGCentogene NV
24/01/202411:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
23/01/202411:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
23/01/202411:30GlobeNewswire Inc.CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using MultiomicsNASDAQ:CNTGCentogene NV
18/01/202412:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
18/01/202411:30GlobeNewswire Inc.CENTOGENE Announces Preliminary Full Year 2023 RevenueNASDAQ:CNTGCentogene NV
19/12/202312:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
19/12/202311:30GlobeNewswire Inc.CENTOGENE Announces Voting Results of Extraordinary General MeetingNASDAQ:CNTGCentogene NV
18/12/202311:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
13/12/202311:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
 Showing the most relevant articles for your search:NASDAQ:CNTG